mbcaUPdate


LATEST NEWS AND PATIENT RESOURCES FROM THE ALLIANCE AND OUR MEMBERS
MBCA Member - BCRF

Breast Cancer Brain Metastases: Clinical Challenges and Recent Advancements


At SABCS 2020, investigators shared current research findings and more By BCRF | January 5, 2021 Tags:  SABCS 2020 Metastatic Research Up to 45 percent of patients with metastatic breast cancer develop brain metastases, and those who do have an average survival of three to 23 months. Researchers are addressing clinical challenges and exploring the biology of

Read More

News

MBC Alliance Announces New Chair and Vice-Chair


The MBC Alliance has announced the transition of Christine Benjamin from Vice-Chair to Chair and the election of Hope Wohl as the new Vice-Chair beginning November 1, 2020. The MBC Alliance is a coalition formed in 2013 by a dozen nonprofit patient advocacy and research organizations; metastatic breast cancer (MBC) patients and independent advocates; and

Read More

FORCE Syndicated Content, News

Study: Factors that affect the ability to work in people with metastatic cancer


Study: Factors that affect the ability to work in people with metastatic cancer Some patients who live with metastatic cancer either want or need to continue working while coping with symptoms of their disease and treatment. A recent study that looked at over 600 people with metastatic breast, prostate, colon, or lung cancer found that

Read More

FORCE Syndicated Content, News

Update: FDA approves new treatment for metastatic triple-negative breast cancer


Update: FDA approves new treatment for metastatic triple-negative breast cancer The FDA approved the use of sacituzumab govitecan-hizy (Trodelvy), a treatment drug for people with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. (4/27/20) Read the article Printer Friendly Page This article is most relevant for: People with

Read More